Midmark Warned Over CAPAs, Supplier Controls

The FDA has warned Midmark after the devicemaker failed to strengthen corrective and preventive action (CAPA) procedures at its Versailles, Ohio, facility as the agency urged in an earlier Form 483.
The GMP Letter